Kim Iversen: NEW Ivermectin Study Touted By Fauci Faithful Has OBVIOUS Flaws

Kim Iversen reacts to The Wall Street Journal write up “”Ivermectin Didn’t Reduce Covid-19 Hospitalizations in Largest Trial to Date.””

According to the CDC: Ivermectin is not authorized or approved by FDA for prevention or treatment of COVID-19. The National Institutes of Health’s (NIH) COVID-19 Treatment Guidelines Panel has also determined that there are currently insufficient data to recommend ivermectin for treatment of COVID-19.

About Rising:
Rising is a weekday morning show with bipartisan hosts that breaks the mold of morning TV by taking viewers inside the halls of Washington power like never before. The show leans into the day’s political cycle with cutting edge analysis from DC insiders who can predict what is going to happen. It also sets the day’s political agenda by breaking exclusive news with a team of scoop-driven reporters and demanding answers during interviews with the country’s most important political newsmakers.

Follow Rising on social media:

Website: Hill.TV

Facebook: facebook.com/HillTVLive/

Instagram: @HillTVLive

Twitter: @HillTVLive